RecruitingNCT05846620

Pulmonary Immune Cell-microbiome Interactions in the Healthy Lung

Pulmonary Immune Cell-microbiome Interactions in the Healthy Lung: the ILLUMINA-2 Study


Sponsor

Hvidovre University Hospital

Enrollment

50 participants

Start Date

Apr 17, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The overall aim is to to provide a normal material for the composition and spatial heterogeneity of the following in the healthy lung: i) immune cell populations and their activation patterns, ii) the surrounding cytokine-chemokine milieu, including trans-compartmental fluxes of these mediators between the lung and bloodstream, and iii) the lung microbiome. Main hypotheses: * Absolute and relative immune cell counts in bronchoalveolar lavage fluid (BALF) are similar to those previously reported by other methods6,7. * No trans-compartmental flux of cytokines between the lungs and bloodstream is present, but cytokine concentrations (notably IL-6 and IL-8) vary with the immune-cell-microbiome composition. * Immune cell (mainly T cell) activation, differentiation, and gene expression patterns are expected to differ between blood and BALF in a manner that depends on the regional diversity of the pulmonary microbiome.


Eligibility

Min Age: 40 YearsMax Age: 75 Years

Inclusion Criteria2

  • Men and women
  • Age 40 to 75

Exclusion Criteria8

  • Immune deficiency
  • Lung disease
  • Active cancer or infection
  • Absolute contraindications for bronchoscopy
  • Untreated malignant arrhythmia
  • Documented or suspected intracranial hypertension (intracranial pressure ≥ > 15 mmHg)
  • One-lung ventilation
  • Severe coagulopathy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBronchoalveolar lavage

Bronchoalveolar lavage in the middle lobe of the right lung and a mini-bronchoalveolar lavage in the upper and lower lobe of the right lung


Locations(1)

Hvidovre Hospital, University of Copenhagen

Hvidovre, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05846620


Related Trials